 CLEVELAND, Jan. 4, 2021 PRNewswire -- ViewRay, Inc. Nasdaq: VRAY, maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 10,310,000 shares of... 